53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details
臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04835623 (ClinicalTrials.gov) | June 21, 2021 | 5/4/2021 | CEQUA for Sjogren's Syndrome Dry Eye | Effects of CEQUA™ on Objective and Subjective Dry Eye Findings Associated With Sjogren's Syndrome | Dry Eye;Dry Eye Syndromes;Sjogren's Syndrome | Drug: Cyclosporine 0.09% Ophthalmic Solution | Center for Ophthalmic and Vision Research, LLC | Sun Pharmaceutical Industries Limited | Recruiting | 18 Years | 70 Years | All | 50 | Phase 4 | United States |